Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

References for PMC Articles for PubMed (Select 18391028)

1.

Response to emerging infection leading to outbreak of linezolid-resistant enterococci.

Kainer MA, Devasia RA, Jones TF, Simmons BP, Melton K, Chow S, Broyles J, Moore KL, Craig AS, Schaffner W.

Emerg Infect Dis. 2007 Jul;13(7):1024-30. doi: 10.3201/eid1307.070019.

2.

Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci.

Tenover FC, Williams PP, Stocker S, Thompson A, Clark LA, Limbago B, Carey RB, Poppe SM, Shinabarger D, McGowan JE Jr.

J Clin Microbiol. 2007 Sep;45(9):2917-22. Epub 2007 Jul 18.

3.

Detection of mutations conferring resistance to linezolid in Enterococcus spp. by fluorescence in situ hybridization.

Werner G, Bartel M, Wellinghausen N, Essig A, Klare I, Witte W, Poppert S.

J Clin Microbiol. 2007 Oct;45(10):3421-3. Epub 2007 May 2.

4.

The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.

Scheetz MH, Qi C, Noskin GA, Warren JR, Postelnick MJ, Malczynski M, Huang J, Zembower TR.

Diagn Microbiol Infect Dis. 2006 Dec;56(4):407-13. Epub 2006 Aug 23.

PMID:
16930924
5.
6.

Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.

Raad II, Hanna HA, Hachem RY, Dvorak T, Arbuckle RB, Chaiban G, Rice LB.

Antimicrob Agents Chemother. 2004 Sep;48(9):3583-5.

7.

Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs.

Ruggero KA, Schroeder LK, Schreckenberger PC, Mankin AS, Quinn JP.

Diagn Microbiol Infect Dis. 2003 Nov;47(3):511-3.

PMID:
14596970
8.

Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis.

Lobritz M, Hutton-Thomas R, Marshall S, Rice LB.

Antimicrob Agents Chemother. 2003 Oct;47(10):3318-20.

9.

Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.

Pai MP, Rodvold KA, Schreckenberger PC, Gonzales RD, Petrolatti JM, Quinn JP.

Clin Infect Dis. 2002 Nov 15;35(10):1269-72. Epub 2002 Oct 28.

10.

Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.

Marshall SH, Donskey CJ, Hutton-Thomas R, Salata RA, Rice LB.

Antimicrob Agents Chemother. 2002 Oct;46(10):3334-6.

11.

Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.

Herrero IA, Issa NC, Patel R.

N Engl J Med. 2002 Mar 14;346(11):867-9. No abstract available.

12.

Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci.

Prystowsky J, Siddiqui F, Chosay J, Shinabarger DL, Millichap J, Peterson LR, Noskin GA.

Antimicrob Agents Chemother. 2001 Jul;45(7):2154-6.

14.

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B.

J Clin Microbiol. 1995 Sep;33(9):2233-9. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk